Full Answer
See more
Eligibility Requirements
The Program is valid only for patients with commercial (also known as private) insurance who are taking the medication for an FDA approved indication.
Additional Terms and Conditions
This Program is only valid for cost of the drug Adcirca, Orenitram, Remodulin or Tyvaso and not applicable to any related supplies or other medical expenses associated with administering the product.
Innovation
We seek to push technology forward for the benefit of patients, with the ultimate goal of developing cures for pulmonary hypertension and other end-stage organ diseases through our organ manufacturing program, which includes multiple technologies and programs to create an unlimited supply of transplantable organs.
Lung Biotechnology
Lung Biotechnology PBC, a wholly owned subsidiary of United Therapeutics, houses our organ manufacturing work which is aimed at dramatically increasing the supply of transplantable organs. It is also the first public benefit corporation ( PBC) subsidiary of a public biotech or pharmaceutical company.
Animal Welfare
United Therapeutics is committed to and abides by all ethical requirements related to animal welfare in research, teaching, and testing. Research involving the use of live animals must be approved by Institutional Animal Care and Use Committees ( IACUC) at both our in-house facilities and our partner institutions, a requirement of U.S.
Patient Safety
Protecting and improving patient health is our most important goal. To ensure our patients’ safety, we have a robust safety governance structure and a comprehensive set of standards designed to ensure that we have proper oversight over pharmacovigilance ( PV) activities.
Supply Chain Management
United Therapeutics maintains a rigorously compliant GxP Quality & Compliance program covering those aspects of our supply chain that could impact the quality and safety of our products. We use more than 700 pre-qualified raw material vendors and service providers to support clinical and commercial business operations.
Patient Support, Education, & Financial Assistance
We take a holistic approach to helping our patients and their families by expanding our focus beyond just treatments and therapies to include a variety of support, education, and assistance programs related to our products. A few of our key programs are outlined on our patients page on our corporate website.
What is the Archways Program?
Understanding your condition and getting started on treatment with TYVASO (inhaled treprostinil) or Orenitram (oral treprostinil) can leave you with questions.
What to Expect with Archways
You may enroll in Archways immediately after you have been prescribed TYVASO or Orenitram by your Healthcare Provider. Once enrolled, you will be contacted by a UT Patient Educator to provide information about your condition, details about your therapy, and what to expect when getting started with the Specialty Pharmacy process.
Join the Archways Program
You must enroll in the Archways program to participate. In order to enroll in the Archways program, you must have a diagnosis of PAH (TYVASO and Orenitram) or PH-ILD (TYVASO only) as well as a prescription for TYVASO or Orenitram. To get started and to learn more about how the UT Virtual Patient Educators can help, click the button below.
Tyvaso Co-Pay Assistance Card
If you have a commercial or private insurance plan, we offer a co-pay assistance card to help cover some of your out-of-pocket expenses.
Patient Assistance Program (PAP)
United Therapeutics offers a free medication program for uninsured and underinsured patients who meet eligibility requirements.
Other financial support resources
There are independent Patient Assistance Programs* available that offer financial assistance to PAH patients in need. Known patient assistance programs that support PAH are listed below, in no particular order.
What is Tyvaso?
TYVASO (treprostinil) is a prescription medicine used in adults to treat pulmonary arterial hypertension (PAH; WHO Group 1), which is high blood pressure in the arteries of your lungs. TYVASO can improve the ability to exercise. Your ability to exercise decreases 4 hours after taking TYVASO.
IMPORTANT SAFETY INFORMATION
Before you take TYVASO, tell your healthcare provider about all of your medical conditions, including if you:
